Brian Kaspar
Brian Kaspar is a leading researcher in the field of gene therapy for spinal muscular atrophy (SMA), known for his role in developing Zolgensma. His work was initially supported by the Gaynor family's charity, Sophia's Cure, but became controversial as he transitioned to a for-profit biotech company, AveXis.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Brian Kaspar was a leading researcher in the development of Zolgensma, the gene therapy for SMA.
5